
Shanghai Titan Scientific Co.,Ltd. — Investor Relations & Filings
Shanghai Titan Scientific Co.,Ltd. provides a comprehensive suite of scientific research products and integrated laboratory solutions. The company specializes in the development and distribution of high-end reagents, laboratory consumables, and analytical instruments. Its product portfolio features proprietary brands such as Adamas-Beta for specialty chemicals and reagents, alongside a broad selection of laboratory equipment and safety supplies. Titan Scientific utilizes an integrated e-commerce platform to facilitate procurement for academic institutions, pharmaceutical companies, and industrial R&D centers. Beyond product supply, the company offers technical services including laboratory design, construction, and information management systems. By implementing a one-stop service model, it supports the research and development lifecycle through a streamlined supply chain and technical support.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 德恒上海律师事务所关于上海泰坦科技股份有限公司2025年年度股东会的法律意见 | 2026-05-26 | Chinese | |
| 关于调整2026年限制性股票激励计划有关事项的公告 | 2026-05-22 | Chinese | |
| 泰坦科技关于召开2025年年度暨2026年第一季度业绩说明会的公告 | 2026-05-20 | Chinese | |
| 上海泰坦科技股份有限公司2025年年度股东会会议资料 | 2026-05-18 | Chinese | |
| 德恒上海律师事务所关于上海泰坦科技股份有限公司2026年第二次临时股东会的法律意见 | 2026-05-08 | Chinese | |
| 关于2026年限制性股票激励计划内幕信息知情人买卖公司股票情况的自查报告 | 2026-05-08 | Chinese |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47077360 | 德恒上海律师事务所关于上海泰坦科技股份有限公司2025年年度股东会的法律意见 | 2026-05-26 | Chinese | ||
| 46867504 | 关于调整2026年限制性股票激励计划有关事项的公告 | 2026-05-22 | Chinese | ||
| 46703117 | 泰坦科技关于召开2025年年度暨2026年第一季度业绩说明会的公告 | 2026-05-20 | Chinese | ||
| 46512457 | 上海泰坦科技股份有限公司2025年年度股东会会议资料 | 2026-05-18 | Chinese | ||
| 44493083 | 德恒上海律师事务所关于上海泰坦科技股份有限公司2026年第二次临时股东会的法律意见 | 2026-05-08 | Chinese | ||
| 44493081 | 关于2026年限制性股票激励计划内幕信息知情人买卖公司股票情况的自查报告 | 2026-05-08 | Chinese | ||
| 44272298 | 关于公司及控股子公司诉讼进展的公告 | 2026-05-07 | Chinese | ||
| 39922003 | 泰坦科技独立董事2025年度述职报告(朱正刚) | 2026-04-29 | Chinese | ||
| 39921989 | 泰坦科技2025年度内部控制自我评价报告 | 2026-04-29 | Chinese | ||
| 39921979 | 泰坦科技2025年度募集资金存放与实际使用情况的专项报告 | 2026-04-29 | Chinese | ||
| 39921970 | 泰坦科技董事、高级管理人员薪酬管理制度 | 2026-04-29 | Chinese | ||
| 39921961 | 泰坦科技董事会对独立董事独立性自查情况的专项报告 | 2026-04-29 | Chinese | ||
| 39921949 | 泰坦科技关于召开2025年年度股东大会的通知 | 2026-04-29 | Chinese | ||
| 39921946 | 2025年营业收入扣除情况专项审核报告 | 2026-04-29 | Chinese | ||
| 39921784 | 大信会计师事务所关于上海泰坦科技股份有限公司2025年度非经营性资金占用及其他关联资金往来情况的专项审核报告 | 2026-04-29 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
Shanghai Titan Scientific Co.,Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/58176/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=58176 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=58176 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=58176 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 58176}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Shanghai Titan Scientific Co.,Ltd. (id: 58176)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.